Robert Bitterman
Vorstandsvorsitzender bei PHIO PHARMACEUTICALS CORP.
Vermögen: 14 525 $ am 30.06.2024
Ursprung des Netzwerks ersten Grades von Robert Bitterman
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 16 | |
Women's Dermatologic Society
12
| Foundation/Endowment | 12 | |
| Subsidiary | Pharmaceuticals: Major | 9 | |
Cutanea Life Sciences, Inc.
 Cutanea Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Cutanea Life Sciences, Inc. Develops and commercialises innovative dermatology related products. The company was founded in May 2005 and is headquartered in Wayne, PA.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Dermik Laboratories, Inc.
 Dermik Laboratories, Inc. Household/Personal CareConsumer Non-Durables Dermik Laboratories, Inc. manufactures health and skin care products. Its products and services include acne, actinic keratosis, nail fungus, dermatitis and eczema, and chemical peels treatment. The company was founded in 1947 and is located in Berwyn, PA.
4
| Operating Division | Household/Personal Care | 4 |
Dermatology Foundation
4
| Non-Profit Organization | 4 | |
Business Leaders Network
1
| Private Company | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Robert Bitterman
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
American Academy of Dermatology
 American Academy of Dermatology Miscellaneous Commercial ServicesCommercial Services American Academy of Dermatology is the largest and most influential dermatology group in the United States. The private company is based in the United States and has subsidiaries in various locations. The American company provides resources on membership, education, practice management, publications, and clinical care for dermatologists. The company also offers information for patients and the public on skin, hair, and nail conditions. Elizabeth Usher has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chairman | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| The University of North Carolina at Charlotte | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| University of Massachusetts | College/University | Graduate Degree Doctorate Degree | |
| CHROMADEX CORPORATION | Pharmaceuticals: Other | Director/Board Member Corporate Officer/Principal | |
| MEDICIS PHARMACEUTICAL CORP | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| Lehigh University | College/University | Undergraduate Degree Undergraduate Degree | |
The Association for Research in Vision & Ophthalmology
 The Association for Research in Vision & Ophthalmology Miscellaneous Commercial ServicesCommercial Services The Association for Research in Vision & Ophthalmology operates an association focused on research in vision and ophthalmology. The non-profit company is based in Rockville, MD. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Masters Business Admin | |
Castle Creek Biosciences, Inc.
 Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| Villanova University | College/University | Graduate Degree Undergraduate Degree | |
| Loyola University of Chicago | College/University | Graduate Degree Undergraduate Degree | |
| New York University | College/University | Masters Business Admin Doctorate Degree | |
American Medical Association
 American Medical Association Miscellaneous Commercial ServicesCommercial Services American Medical Association engages in promoting the art and science of medicine and the betterment of public health. It offers services to physicians, residents, medical students, and patients. The company was founded by Nathan Smith Davis in 1847 and is headquartered in Chicago, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Wisconsin | College/University | Undergraduate Degree Undergraduate Degree | |
| The Medical College of Wisconsin, Inc. | College/University | Doctorate Degree Doctorate Degree | |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| Lafayette College | College/University | Undergraduate Degree | |
| BOSTON SCIENTIFIC CORPORATION | Medical Specialties | Director/Board Member | |
| Philadelphia University | College/University | Undergraduate Degree | |
| Columbia Business School | College/University | Masters Business Admin | |
| Ursinus College | College/University | Undergraduate Degree | |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
SciVac Ltd.
 SciVac Ltd. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., SciVac Ltd. is an Israeli company that develops and markets biological products for human healthcare. The company is based in Rehovot, Israel. SciVac was acquired by Levon Resources Ltd. on July 09, 2015 for $73.16 million. | Biotechnology | Chief Executive Officer | |
| TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Virginia Commonwealth University | College/University | Doctorate Degree | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member | |
| VBI VACCINES INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University of California San Diego | College/University | Corporate Officer/Principal | |
| TELETOUCH COMMUNICATIONS, INC. | Specialty Telecommunications | Director/Board Member | |
Xenetic Biosciences (UK) Ltd.
 Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chief Operating Officer | |
| Pediatric Dermatology Society | Corporate Officer/Principal | ||
| ELAN CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Giiant Pharma, Inc.
 Giiant Pharma, Inc. BiotechnologyHealth Technology Giiant Pharma, Inc. is a Canadian preclinical-stage biotech company that specializes in designing gut-restricted small molecule drug therapeutics with various biological targets in gastroenterology. The company is based in Montréal, Canada and was founded by Elizabeth Elizabeth Kwong. The company's proprietary precision delivery technology platform allows for the creation of tissue-specific drugs with improved tolerability and enhanced therapeutic effects. Giiant's first lead program, GT-2108, is a microbiota-activated PDE4 inhibitor prodrug. Maxime Ranger has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
Orthogon Therapeutics LLC
 Orthogon Therapeutics LLC Pharmaceuticals: MajorHealth Technology Orthogon Therapeutics LLC is a privately held R&D firm that specializes in drug discovery and development. The company is based in Canton, MA. The company is headquartered in the biotech hub of Greater Boston and has a branch in Leuven. Orthogon uses an innovative structure-based and biophysics platform to design novel medicines. The company's portfolio of infectious disease assets includes antiviral therapeutics, with a lead program being a first-in-class, orally administrable small molecule inhibitor of BK virus replication. Orthogon has secured over $12.50m in investment to date and has additional discovery programs, including a treatment for antibiotic-resistant bacterial infections. The company was founded by Ali Munawar, a veteran biotech entrepreneur, and experienced drug discovery scientists with a mission to prolong and improve patient quality of life. | Pharmaceuticals: Major | Director/Board Member | |
| BioCurate Pty Ltd. | Director/Board Member | ||
FutuRx Ltd.
 FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Investment Managers | Consultant / Advisor | |
DermAvance Pharmaceuticals, Inc.
 DermAvance Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology DemAvance Pharmaceuticals, Inc. manufactures and distributes dermatology pharmaceutical products. Its products include arnika forte, hyalogy, hydro-Q, tret-A and pur-sil. The firm markets and sells both prescription and cosmeceutical products to dermatologists and aesthetic physicians in order to meet the rapidly growing patient demand for facial skin rejuvenation products. the company was founded by Keith A. Greathouse in March 2006 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Chief Executive Officer | |
| San Jose State University | College/University | Undergraduate Degree | |
The Skin Cancer Foundation
 The Skin Cancer Foundation Miscellaneous Commercial ServicesCommercial Services The Skin Cancer Foundation engages in educating about skin cancer to the public, medical, and community. The company was founded by Perry Robins in 1979 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
| New York College of Podiatric Medicine | College/University | Corporate Secretary |
Statistik
International
| Vereinigte Staaten | 43 |
| Israel | 4 |
| Vereinigtes Königreich | 2 |
| Japan | 2 |
| Schweiz | 2 |
Sektoral
| Health Technology | 22 |
| Consumer Services | 17 |
| Commercial Services | 8 |
| Finance | 3 |
| Health Services | 2 |
Operativ
| Corporate Officer/Principal | 99 |
| Director/Board Member | 85 |
| Chief Tech/Sci/R&D Officer | 27 |
| Independent Dir/Board Member | 27 |
| Chief Executive Officer | 26 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Geert Cauwenbergh | 22 |
| Martin Schmieg | 20 |
| Curtis Lockshin | 20 |
| Marie Lindner | 18 |
| Mary Fisher | 15 |
| Mary Spellman | 14 |
| Mitchell Wienick | 14 |
| Keith A. Greathouse | 11 |
| Alexey V. Eliseev | 11 |
| Jonathan Freeman | 10 |
| Keith Brownlie | 10 |
| Lawrence H. Pearson | 10 |
| John A. Barrett | 10 |
| Lincoln Krochmal | 9 |
| Susan Stranahan Ciallella | 8 |
- Börse
- Insiders
- Robert Bitterman
- Unternehmensverbindungen
